Skip to main content

Advertisement

SpringerLink
Log in

X-linked Hyper-IgM Syndrome Associated with Poorly Differentiated Neuroendocrine Tumor Presenting as Obstructive Jaundice Secondary to Extensive Adenopathy

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

X-Linked Hyper IgM Syndrome (XHIGM) is a rare B-cell immunodeficiency disease. Patients with XHIGM are unable to switch immunoglobulin production from IgM to IgG, IgA, and IgE. Patients with XHIGM require periodic intravenous immune globulin to help prevent infections, and are also at risk for a variety of neoplasms. We describe a young man with XHIGM who presented with obstructive jaundice from malignant adenopathy from widespread, poorly differentiated neuroendocrine tumor. This has not previously been reported and represents a new association with XHIGM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Vincent JL (1992) Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study. Chest 101:810–815

    PubMed  CAS  Google Scholar 

  2. Durandy A, Honjo T (2001) Human genetic defects in class-switch recombination (hyper-IgM syndromes). Curr Opin Immunol 13:543–548

    Article  PubMed  CAS  Google Scholar 

  3. Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T, Fu SM, Stamenkovic I, Geha RS (1993) Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A 90:2170–2173

    Article  PubMed  CAS  Google Scholar 

  4. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G (1993) CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361:541–543

    Article  PubMed  CAS  Google Scholar 

  5. Notarangelo LD, Peitsch MC (1996) CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 17:511–6

    Article  PubMed  CAS  Google Scholar 

  6. Fuleihan RL (2001) Hyper IgM syndrome: the other side of the coin. Curr Opin Pediatr 13:528–532

    Article  PubMed  CAS  Google Scholar 

  7. Tsuge I, Matsuoka H, Nakagawa A, Kamachi Y, Aso K, Negoro T, Ito M, Torii S, Watanabe K (1998) Necrotizing toxoplasmic encephalitis in a child with the X-linked hyper-IgM syndrome. Eur J Pediatr 157:735–737

    Article  PubMed  CAS  Google Scholar 

  8. Cunningham CK, Bonville CA, Ochs HD, Seyama K, John PA, Rotbart HA, Weiner LB (1999) Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. J Pediatr 134:584–588

    Article  PubMed  CAS  Google Scholar 

  9. Winkelstein JA, Marinao MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME (2003) The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 82:373–384

    Article  CAS  Google Scholar 

  10. Leiva LE, Junprasert J, Hollenbaugh D, Sorensen RU (1998) Central nervous system toxoplasmosis with an increased proportion of circulating gamma delta T cells in a patient with hyper-IgM syndrome. J Clin Immunol 18:283–290

    Article  PubMed  CAS  Google Scholar 

  11. Levy J, Espanel-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Pietsch MC, Notarangelo LD (1997) Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131:47–54

    Article  PubMed  CAS  Google Scholar 

  12. de Gorgolas M, Erice A, Gil A, Gutierrez J, Rivas P, Hernando C, Rodriguez MC (2005) Cryptococcal meningitis in a patient with X-linked hyper-IgM1 syndrome. Scand J Infect Dis 37:526–528

    Article  PubMed  Google Scholar 

  13. Notarangelo LD, Duse M, Ugazio AG (1992) Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 3:101–121

    PubMed  CAS  Google Scholar 

  14. Hayward AR, Levy J, Fachetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M, Weinberg A (1997) Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 158: 977–983

    PubMed  CAS  Google Scholar 

  15. Rodriguez C, Carrion F, Marinovic MA, Chavez E, Preisler J, Pooley F, Futatani T, Ochs HD (2003) [X-linked hyper-IGM syndrome associated to sclerosing cholangitis and gallbladder neoplasm: clinical case]. Rev Med Chil 131:303–308

    PubMed  Google Scholar 

  16. Dimicoli S, Bensoussan D, Latger-Cannard V, Straczek J, Antunes L, Mainard L, Dao A, Barbe F, Araujo C, Clement L, Feugier P, Lecompte T, Stoltz JF, Bordigoni P (2003) Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndrome. Bone Marrow Transplant 32:733–737

    Article  PubMed  CAS  Google Scholar 

  17. Lin SC, Shyur SD, Ma YC, Huang LH, Lee HC, Lee WI (2005) Recurrent acalculous cholecystitis and sclerosing cholangitis in a patient with X-linked hyper-immunoglobulin M syndrome. J Formos Med Assoc 104:421–426

    PubMed  Google Scholar 

  18. Zirkin HJ, Levy J, Katchko L (1996) Small cell undifferentiated carcinoma of the colon associated with hepatocellular carcinoma in an immunodeficient patient. Hum Pathol 27:992–996

    Article  PubMed  CAS  Google Scholar 

  19. Gallerani I, Innoncenti DD, Coronella G, Berti S, Amato L, Moretti S, Fabbri P (2004) Cutaneous sarcoid-like granulomas in a patient with X-linked hyper-IgM syndrome. Pediatr Dermatol 21:39–43

    Article  PubMed  Google Scholar 

  20. Nagasawa M, Itoh S, Sawada Y, Morio T, Nonoyama S, Mitzutani S (2004) Coagulopathy in a patient with X-linked hyper-IgM syndrome who developed Kaposi’s sarcoma. Am J Hematol 75:116–117

    Article  PubMed  Google Scholar 

  21. Kloppel G, Anlauf M (2005) Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 19:507–517

    Article  PubMed  Google Scholar 

  22. Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, Di Fonzo M, Tornatore V, Milione M, Angeletti S, Cattaruzza MS, Ziparo V, Bordi C, Pederzoli P, Delle Fave G (2005) Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 12:1083–1092

    Article  PubMed  Google Scholar 

  23. Plockinger U, Wiedenmann B (2005) Endocrine tumours of the gastrointestinal tract. Management of metastatic endocrine tumours. Best Pract Res Clin Gastroenterol 19:553–576

    Article  PubMed  CAS  Google Scholar 

  24. Schillaci O, Spanu A, Scopinaro F, Falchi A, Corleto V, Danieli R, Marongiu P, Pisu N, Madeddu G, Delle Fave G, Madeddu G (2003) Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors. Int J Oncol 23:1687–1695

    PubMed  CAS  Google Scholar 

  25. Mitry E, Baudin E, Ducreus M, Sabourin JC, Rufie P, Aparicio T, Aparicio T, Lasser P, Elias D, Duvillard P, Schlumberger M, Rougier P (1999) Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 81:1351–1355

    Article  PubMed  CAS  Google Scholar 

  26. Moertel CG, Kvols LK, O’Connell MJ, Rubin J (1991) Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 68:227–232

    Article  PubMed  CAS  Google Scholar 

  27. Mitry E, Rougier P (2001) The treatment of undifferentiated neuroendocrine tumors. Crit Rev Oncol Hematol 37:47–51

    Article  PubMed  CAS  Google Scholar 

  28. Fjallskog ML, Granberg DP, Welin SL, Eriksson C, Oberg KE, Janson ET, Eriksson BK (2001) Treatment with cisplatin and etoposide in patients with neuroendocrine tumors. Cancer 92:1101–1107

    Article  PubMed  CAS  Google Scholar 

  29. Bajetta E, Procopio G, Ferrari L, Catena L, Del Vecchio M, Bombardieri E (2003) Update on the treatment of neuroendocrine tumors. Expert Rev Anticancer Ther 3:631–642

    Article  PubMed  CAS  Google Scholar 

  30. Della Torre S, Procopio G, Fusi A, Catena L, Ferrari L, Nova P, Denaro A, Bichisao E, Bajetta E (2003) Current treatments of neuroendocrine tumors role of biotherapy and chemotherapy. Tumori 89:111–116

    PubMed  Google Scholar 

  31. Ollivier S, Fonck M, Becouarn Y, Brunet R (1998) Dacarbazine, fluorouracil, and leucovorin in patients with advanced neuroendocrine tumors: a phase II trial. Am J Clin Oncol 21:237–240

    Article  PubMed  CAS  Google Scholar 

  32. Arnold R, Rinke A, Schmidt Ch, Hofbauer L (2005) Endocrine tumours of the gastrointestinal tract: chemotherapy. Best Pract Res Clin Gastroenterol 19:649–656

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Huntsman Cancer Center, University of Utah, Salt Lake City, Utah, USA

    Nandini Nagaraj, Chukwuma Egwim & Douglas G. Adler

Authors
  1. Nandini Nagaraj
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chukwuma Egwim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Douglas G. Adler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Douglas G. Adler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagaraj, N., Egwim, C. & Adler, D.G. X-linked Hyper-IgM Syndrome Associated with Poorly Differentiated Neuroendocrine Tumor Presenting as Obstructive Jaundice Secondary to Extensive Adenopathy. Dig Dis Sci 52, 2312–2316 (2007). https://doi.org/10.1007/s10620-006-9702-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9702-3

Keywords

Search

Navigation